At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 170 enrolled
Drug / intervention
LASIK correction of myopic refractive errorsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Myopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and Star S4IR™ Excimer Laser
In Brief
A Phase 3 clinical trial evaluating LASIK correction of myopic refractive errors for Myopia. Completed, enrolled 170 participants.
Detailed Summary
The purpose of this clinical trial is to demonstrate that wavefront-guided LASIK is safe and effective for the correction of myopic refractive errors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2012
First PostedAug 2012
Primary CompletionMar 2014
Study CompletionJul 2015
TodayJul 2026
First PostedAug 13, 2012
Enrollment StartAug 1, 2012
Primary CompletionMar 1, 2014
Study CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 13.9 years ago
Interventions
LASIK correction of myopic refractive errorsdevice
Surgeons will perform wavefront-guided LASIK based upon measurement obtained with the iDesign System